PLANNING FOR GENE THERAPY success
With clinical trial successes bringing gene therapy closer to FDA approval and eventual commercialization, it's critical for companies developing gene therapies to understand the marketplace and plan accordingly.
RxC International has put together a white paper containing important information on the current state of gene therapies, companies driving the market forward, and what to consider when beginning the process of commercialization.
CRITICAL QUESTIONS FOR ADDRESSING THE GENE THERAPY Marketplace
What diseases are closest to having gene therapies approved as treatment options?
What elements are required for a gene therapy to be successful?
What are the critical commercial issues companies developing gene therapies need to address?